If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marco Imperatori is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Renal Cell Carcinoma Medicine & Life Sciences
Vascular Endothelial Growth Factor Receptor Medicine & Life Sciences
Expert Testimony Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences
lenvatinib Medicine & Life Sciences
Everolimus Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2018

Adjuvant treatment for EGFR-mutated non-small cell lung cancer: do we have a major breakthrough?

Roviello, G., Imperatori, M., Aieta, M., Sollitto, F. & Landriscina, M., Jul 2018, In : Journal of Thoracic Disease. 10, Suppl 18, p. S2114-S2118

Research output: Contribution to journalArticle

Lenvatinib for the treatment of renal cell carcinoma

Roviello, G., Corona, S. P., Bozza, G., Aieta, M., Generali, D., Rodriquenz, M. G., Mileo, A. M., Imperatori, M., Ianza, A., Conca, R. & Sobhani, N., May 2018, In : Expert Opinion on Investigational Drugs. 27, 5, p. 507-512 6 p.

Research output: Contribution to journalReview article

Renal Cell Carcinoma
Vascular Endothelial Growth Factor Receptor
Expert Testimony